PPIA and ovarian carcinoma: Wang and colleagues (20) used SRM method to detect peptide biomarkers and found that 11 (64.7%) of 17 patients with early ovarian cancer had positive scores of small peptides from peptidyl prolyl cis-trans isomerase A(PPIA), which may be a useful diagnostic marker for ovarian cancer.